glp-1 agonist alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus GLP-1 Agonists For Obesity In
Description
This would be in line with a recent propensity-score matched cohort study by our laboratory, which observed that semaglutide was associated with reduced cognitive deficit and nicotine misuse when compared against three other antidiabetic medications 227

[1] These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
The study specifically highlighted that People with diabetes may have a lower risk of serious clots with GLP-1 drugs than with some other diabetes medications

They called the chemical substance 'secretin'

Post-meal pharmacodynamic profile of AVE0010, a once-daily GLP-1 receptor agonist, in patients with type 2 diabetes inadequately controlled on metformin (Abstract) Diabetologia
:max_bytes(150000):strip_icc()/DiabetesMentalHealth2-73d13703a7c3442ca4fce0a2e71f15b0.jpg)
What's more, the GLP-1 Companion has high daily-to-monthly usage ratios, reflecting a level of engagement more on par with a social application than a behavior change program
